Vascular Biogenics Aktie Analyse
| 27.06.19 | Vascular Biogenics Outperform | Oppenheimer & Co. Inc. | |
| 09.03.18 | Vascular Biogenics Neutral | Chardan Capital Markets | |
| 08.03.18 | Vascular Biogenics Neutral | H.C. Wainwright & Co. | |
| 06.11.17 | Vascular Biogenics Buy | Chardan Capital Markets | |
| 28.06.16 | Vascular Biogenics Buy | H.C. Wainwright & Co. | |
| 23.10.15 | Vascular Biogenics Buy | Chardan Capital Markets | |
| 28.09.15 | Vascular Biogenics Buy | ROTH Capital Partners, LLC | |
| 22.09.15 | Vascular Biogenics Buy | Chardan Capital Markets | |
|
Werbung
|
|||
| 22.05.15 | Vascular Biogenics Buy | ROTH Capital Partners, LLC | |
| 27.10.14 | Vascular Biogenics Outperform | Oppenheimer & Co. Inc. | |